Research Article| Volume 24, ISSUE 1, P22-26, July 1967

Systemic lupus erythematosus with circulating anticoagulant discovered after postextraction hemorrhage

      This paper is only available as a PDF. To read, Please Download here.


      Systemic lupus erythematosus may be accompanied by a circulating anti-coagulant or other clotting abnormality. A report has been presented in which an unsuspected case of systemic lupus erythematosus with circulating anticoagulant was diagnosed in a patient only after an episode of postextraction hemorrhage.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • Harrison T.R.
        • Adams R.D.
        • Bennett I.L.
        • Resnick W.H.
        • Thorn G.W.
        • Wintrobe M.M.
        Principles of Internal Medicine.
        in: ed 4. McGraw-Hill Book Company, Inc, New York1962: 1895
        • Hargraves M.M.
        Presentation of Two Bone Marrow Elements: The “Tart” Cell and the “L. E.” Cell.
        in: ed. 3. Proc. Staff Meet. Mayo Clin. 23. 1948: 25
        • Weiss R.S.
        • Swift S.
        The Significance of a Positive L. E. Phenomenon.
        Arch Dermat. 1955; 72: 103
        • Conley C.L.
        • Hartmann R.C.
        A Hemorrhagic Disorder Caused by Circulating Anti-coagulant in Patients With Disseminated Lupus Erythematosus.
        J. Clin. Invest. 1952; 31: 621
        • Margolis A.
        • Jackson D.P.
        • Ratnoff O.D.
        Circulating Anti-coagulants: A Study of 40 Cases and a Review of the Literature.
        Medicine. 1961; 40: 145
        • Dacie J.V.
        • Lewis S.M.
        Practical Haematology.
        in: ed. 3. Grune & Stratton, Inc, New York1963: 235-236
        • Breckinridge R.T.
        • Ratnoff O.D.
        Studies on the Site of Action of a Circulating Anti-coagulant in Disseminated Lupus Erythematosus.
        Am. J. Med. 1963; 35: 813
        • Biggs R.
        • Denson K.W.
        The Mode of Action of a Coagulation Inhibitor in the Blood of Two Patients With Disseminated Lupus Erythematosus.
        Brit. J. Haemat. 1964; 10: 198
        • Lee S.L.
        • Sanders M.
        A Disorder of Blood Coagulation in Systemic Lupus Erythematosus.
        J. Clin. Invest. 1955; 34: 1814
        • Frick P.G.
        Acquired Circulating Anti-coagulants in Systemic “Collagen Disease”; Autoimmune Thromboplastic Deficiency.
        Blood. 1955; 10: 691
        • Meacham G.C.
        • Weisberger A.S.
        Unusual Manifestations of Disseminated Lupus Erythematosus.
        Ann. Int. Med. 1955; 43: 143
        • Mueller J.F.
        • Ratnoff O.D.
        • Heinle R.W.
        Observation on the Characteristics of an Unusual Circulating Anticoagulant.
        J. Lab. & Clin. Med. 1951; 38: 254
        • Dameshek W.
        Systemic Lupus Erythematosus: A Complex Autoimmune Disorder?.
        Ann. Int. Med. 1958; 48: 707
        • Swift S.
        A Serum Anti-coagulant Factor in Systemic Lupus Erythematosus.
        Arch. Dermat. 1956; 74: 296
        • Ramat B.
        • Singer K.
        An Unusual Circulating Anticoagulant in Systemic Lupus Erythematosus.
        Acta haemat. 1956; 16: 158
        • Harvey A.M.
        • Shulman L.E.
        • Tumulty P.A.
        • Conley C.L.
        • Schoenrich E.H.
        Systemic Lupus Erythematosus: Review of the Literature and Clinical Analysis of 138 Cases.
        Medicine. 1954; 33: 291
        • Laurell A.
        • Nilsson I.M.
        Hypergammaglobulinemia, Circulating Anti-coagulant and Biologic False Positive Wassermann Reaction.
        J. Lab. & Clin. Med. 1957; 49: 694
        • Beaumont J.L.
        Syndrome hemorragique acquis du a un anti-coagulant cirulant.
        Sang. 1954; 25: 1